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ABSTRACT 
Atypical mycobacterium is rarely seen as a cause of chronic mastoiditis but has been increasingly recognized over 
the  past  few  years.  Mycobacterium  abscessus  is  the  most  pathogenic  and  chemotherapy-resistant,  rapid-growing 
mycobacterium of all the four groups. This paper presents a case of a 57-year-old woman who had chronic mastoiditis 
with recurrent exacerbations. The initial computed tomography (CT) findings showed the presence of an inflammatory 
process and she was treated with the appropriate antibiotics. The patient subsequently underwent a tissue biopsy when 
she presented with another exacerbation. At this time, the CT scan did not identify the ongoing exacerbation, but the 
Gallium-67 scintigraphy did. © 2008 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Atypical mycobacterium is a rare entity implicated 
in de novo mastoiditis. There are very few reported cases 
especially  in  the  South-East  Asian  region.  Various 
strains of atypical mycobacterium have been known to 
cause disease in human beings, since their isolation in 
the 1920s. Of the four groups of atypical mycobacterium, 
the group IV rapid growers (Mycobacterium abscessus 
and  Mycobacterium  fortuitum)  are  the  ones  which  are 
recognized as human pathogens [1]. 
This paper presents a case of a 57-year-old woman 
who had chronic recurring mastoiditis and discusses the 
computed tomography (CT) findings and the use of the 
Gallium-67 scintigraphy in this condition. 
CASE REPORT 
A 57-year-old woman, presented to the ENT clinic 
with gradual loss of hearing and bilateral ear discharge. 
She also noticed that pieces of bone were extruding from 
her left ear. She had been suffering from chronic bilateral 
ear discharge since her early teenage years. The physical 
examination  done  by  the  otorhinolaryngologist  had 
shown some ear discharge, but there was no evidence of 
abscess formation, nor was there any facial nerve palsy 
noted.  A  presumptive  diagnosis  of  bilateral  chronic 
suppurative  otitis  media  was  made.  Her  blood 
investigations  were  essentially  normal  apart  from  the 
normocytic normochromic anemia. Ear swabs from the 
external  auditory  canal  were  sent  for  microbiological 
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analysis (culture and sensitivity) for pathogens, including 
Mycobacterium tuberculosis.  
A CT scan of the temporal bones revealed sclerosis 
of  both  mastoid  air  cells  with  presence  of  soft  tissue, 
bony  erosion  and  bony  fragments  within  the  external 
auditory  canal  (Figures  1  and  2).  She  was  started  on 
treatment  with  oral  co-trimoxazole  because  the  initial 
clinical  diagnosis  prior  to  the  imaging  studies  was 
chronic  suppurative  otitis  media.  Her  ear  discharge 
resolved  and  her  hearing  improved.  The  cultures  were 
negative  for  pathogens,  including  tuberculosis.  After 
completing two months of oral antibiotics, she began to 
notice discharge from her right ear. Due to the recurrent 
nature of the infection, a tissue biopsy of the ear was 
performed and sent for culture and sensitivity screening. 
The  tissue  biopsy  of  the  affected  ear  isolated  a 
rapidly  growing  atypical  mycobacterium  – 
Mycobacterium  abscessus  which  was  resistant  to  co-
trimoxazole  (Bactrim)  but  sensitive  to  imipenem 
(intravenous beta-lactam antibiotics), clarithromycin and 
azithromycin.  She  was  commenced  on  imipenem  and 
clarithromycin. Intravenous amikacin was administered 
initially  for  synergistic  reasons  but  the  patient  was 
unable  to  tolerate  amikacin  and  it  was  withheld.  This 
dual antibiotic regime  was continued for a total of 40 
days without any complications. 
A  repeat  CT  scan  of  the  temporal  bone  showed 
consolidation of the previously inflamed bony lesions but 
was  unable  to  give  any  information  on  the  activity  of 
infection. A Gallium-67 (
67Ga) scan was performed and 
showed  raised 
67Ga  uptake  in  the  right  petromastoid 
region (Figures 3 and 4). The left petromastoid region 
showed  near  normal,  but  slightly  increased  radiotracer 
uptake.  This  indicated  the  presence  of  active  infection 
and the need to continue treatment.   
Upon  completing  the  initial  regime  of  antibiotics, 
she  was  started  on  oral  doxycycline  100mg  bd, 
clarithromycin  500mg  bd  and  moxifloxacin  400mg  bd 
for life. She has been on regular follow up since then and 
has been well. 
DISCUSSION 
Mycobacteria  are  slow-growing  aerobic,  immobile 
bacilli that have been identified by the property of acid-
fastness. Atypical or non-tuberculous Mycobacteria have 
been distinguished from the Mycobacterium tuberculosis 
complex  and  classified  into  four  groups  by  Runyon 
based  on  the  speed  of  growth,  morphology  and 
biochemical  reactions  [1].  Atypical  mycobacteria  are 
known  to  cause  other  clinical  syndromes  such  as 
lymphadenitis in children, lung and cutaneous infections 
in  adults,  and  disseminated  infections  in 
immunosuppressed  patients.  They  are  isolated  and 
transmitted through contaminated water. Geographically, 
 
 
Figure 1  CT scan of temporal bone - Coronal reconstruction image showing soft tissue filling up the external 
auditory canal and the middle ear (long white arrows). There are also bony fragments seen (short black 
arrows). 
 
 
Figure 2  CT of temporal bone - axial image, in bone window 
showing  soft  tissue  filling  up  the  external  auditory 
canal  and  the  middle  ear  (long  white  arrows).  The 
bony fragments are clearly seen in this window. (short 
black arrows). 
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Figure 3 
67Ga scintigraphy showing uptake in the right mastoid region. (black arrow). 
 
 
 
 
 
Figure 4  SPECT 
67Ga  scintigraphy  images  showing  significantly  increased  uptake  in  the  right  petromastoid 
region. (black arrow). 
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outbreaks of atypical mycobacterial infection have been 
reported especially in the Rocky Mountain territories of 
North America [1, 2]. 
Mycobacterium abscessus (previously known as M. 
chelonae,  subspecies  abscessus)  is  a  rare  cause  of 
chronic  mastoiditis,  as  less  than  10  cases  have  been 
reported  so  far.  According  to  Redaelli  de  Zinis  et  al, 
there were only seven cases of otitis media caused by 
Mycobacterium  abscessus  from  1976  to  2001  [2]. 
Mycobacterium  abscessus  is  the  most  pathogenic  and 
chemotherapy-resistant  rapid-growing  mycobacteria 
commonly  associated  with  penetrating  trauma,  surgery 
and the presence of foreign bodies. It is also one of the 
mycobacteria  that  are  most  often  isolated  from  cystic 
fibrosis patients [3]. 
Infection caused by atypical mycobacterium in the 
petro-mastoid  region  causes  significant  diagnostic  and 
prognostic  confusion.  There  are  no  definite  CT  scan 
appearances to convince the clinician of the presence of 
residual  infection.  At  this  juncture,  it  is  of  value  to 
follow  up  such  cases  with  Gallium-67  (
67Ga  ) 
scintigraphy  [4].  From  a  clinical  standpoint,  objective 
evidence of resolution of infection will help to guide the 
management  of  these  patients.  It  will  allow  the 
discontinuation  of  prolonged  antibiotic  therapy,  which 
may be expensive and potentially toxic.  
The mechanism of 
67Ga localization in inflamed and 
infected tissue is believed to occur through three main 
processes. 
67Ga is carried bound to plasma transferrins to 
sites  of  inflammation  and  infection.  It  is  also  retained 
within  the  intracellular  lactoferrin  of  leucocytes  which 
will  then  migrate  and  accumulate  at  infection  sites. 
Finally, 
67Ga  itself  may  be  bound  to  the  siderophores 
produced by pathogenic organisms localized at infection 
sites  [4].  It  localizes  very  early  and  in  relatively  high 
concentrations in the event of inflammation of the bony 
tissue.  This  makes  it  the  preferred  technique  for 
assessing  resolution  of  infection  and  to  diagnose 
subclinical mastoiditis [4, 5]. The improvement or return 
to normal of 
67Ga uptake at infection sites correlates well 
with the clinical inactivity of the infection. 
67Ga-citrate also accumulates in sites of active bone 
remodeling but the intensity of uptake is relatively higher 
in the presence of infection and it is less likely to persist 
following  resolution  of  infection.  Thus  used  in 
combination,  technetium-based  agents  and 
67Ga  would 
be useful in both diagnosing as well as in the follow-up 
of these cases [6].  
In a study done by Strashun AM and colleagues in 
1984,  it  was  found  that  clinically  confirmed  cases  of 
otitis media were often radiographically negative early in 
the  course  of  the  disease.  However,  radionuclide 
scintigraphy  with  technetium  and  gallium 
radiopharmaceuticals,  have  been  demonstrated  to  be  a 
more  sensitive  imaging  modality  [4].  Although  CT  is 
excellent  for  the  localization  and  follow  up  of 
progression of soft tissue in the petromastoid region, it 
cannot be used accurately in the follow up of regression 
or inactivity of infection in this region [5]. This is due to 
the slow process of re-ossification in the skull bone. 
CT  is  not  significantly  more  sensitive  (33%)  than 
routine radiographic techniques. Presumably this failure 
of early detection is due to the clinical situation in which 
the  inflammatory  response,  both  soft  tissue  and  bone, 
causes  severe  and  persistent  ear  pain  that  forces  the 
patient to seek attention only at the point in the disease 
where 30-50% of trabecular bone has been destroyed.  
Additionally, the regional anatomy does not provide 
the  same  advantages  of  earlier  soft-tissue  changes 
including  swelling  and  displacement  of  contiguous  fat 
lines, swelling and obliteration of lucent planes between 
muscles  and  subcutaneous  edema,  relied  upon 
radiographically to suggest the possibility of early long-
bone osteomyelitis [4]. 
In  this  patient,  the  Mycobacterium  abscessus 
isolated was resistant to co-trimoxazole. It is important to 
note that the patient was on a single therapy regimen for 
two weeks on this particular antibiotic. This was because 
the  initial  working  diagnosis  was  chronic  suppurative 
otitis media and co-trimoxazole is one of the antibiotics 
utilized in this condition. Furthermore, the culture and 
sensitivity  of  the  ear  swabs  were  not  known  at  the 
initiation of therapy. Nevertheless, the initial discharge 
had cleared with clinical improvement after two months 
of  treatment.  It  is  likely  that  the  Mycobacterium 
abscessus  pathogen  was  initially  sensitive  to  co-
trimoxazole, however, as it was only a mono-therapy, the 
pathogen gradually developed resistance and the patient 
became symptomatic again [7].  
Atypical rapidly-growing mycobacteria are resistant 
to  conventional  antimycobacterial  therapy,  except 
aminoglycosides. New drugs such as clarithromycin and 
erythromycin  derivatives,  with  slightly  greater  activity 
than  the  parent  compound  and  fewer  side  effects  than 
erythromycin, have proven to be effective in treating M. 
chelonei infections [8]. The role of life-long antibiotic 
therapy is still under trial and is used at a few centres 
worldwide.  
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